Imidazopyridazines as P13k lipid kinase inhibitors

Details for Australian Patent Application No. 2007315233 (hide)

Owner Novartis AG

Inventors Stauffer, Frederic; Capraro, HansGeorg; Imbach, Patricia; Furet, Pascal

Agent Davies Collison Cave

Pub. Number AU-A-2007315233

PCT Pub. Number WO2008/052733

Priority 07104782.3 23.03.07 EP; 06123143.7 30.10.06 EP

Filing date 29 October 2007

Wipo publication date 8 May 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/052733 Priority application(s): WO2008/052733

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007315234-Heterocyclic compounds as antiinflammatory agents

2007315217-Modular laboratory apparatus for analysis and synthesis of liquids and method for analysis and synthesis of liquids